Day One Biopharmaceuticals, Inc. (DAWN) Tops Q1 EPS by 7c

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) reported Q1 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $30.76 million versus the consensus estimate of $31.34 million.

For earnings history and earnings-related data on Day One Biopharmaceuticals, Inc. (DAWN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Western Digital (WDC) call put ratio 1 call to 1 put as share price down 1.3%
• Microsoft (MSFT) spreader of 2800 contracts of October 455 puts and October 490 calls